US cardiologyPub Date : 2025-02-10eCollection Date: 2025-01-01DOI: 10.15420/usc.2024.43
Deitrich Gerlt, Sharon Mathai, Kristopher Aten, Colin Ly, Matthew Cali, Ursa Petric, A Nasser Khan
{"title":"Recurrent Idiopathic Methicillin-sensitive Staphylococcus aureus Pericarditis in a Patient with SARS-CoV-2 Infection and Septic Bacteremia: Case Report.","authors":"Deitrich Gerlt, Sharon Mathai, Kristopher Aten, Colin Ly, Matthew Cali, Ursa Petric, A Nasser Khan","doi":"10.15420/usc.2024.43","DOIUrl":"10.15420/usc.2024.43","url":null,"abstract":"<p><p>Purulent pericarditis (PPc) is a rare but clinically significant form of pericarditis that is typically associated with severe infection. Diagnosis is made by aspirating purulent fluid from the pericardial space, although cultures or gram stains of this fluid often yield negative results. Early detection and treatment are important in preventing severe complications such as cardiac tamponade, persistent infection, and the need for advanced therapies. This report describes the case of a 56-year-old man with multiple comorbidities, including diabetic ketoacidosis, COVID-19, and methicillin-sensitive <i>Staphylococcus aureus</i> (MSSA) bacteremia, who was diagnosed with PPc after developing early cardiac tamponade and undergoing successful pericardiocentesis.</p>","PeriodicalId":93393,"journal":{"name":"US cardiology","volume":"19 ","pages":"e03"},"PeriodicalIF":0.0,"publicationDate":"2025-02-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11865670/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143525423","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
US cardiologyPub Date : 2025-01-09eCollection Date: 2025-01-01DOI: 10.15420/usc.2024.34
Nicholas Nguyen, Katherine C Michelis
{"title":"Pharmacotherapy, Lifestyle Modification, and Cardiac Rehabilitation after Myocardial Infarction or Percutaneous Intervention.","authors":"Nicholas Nguyen, Katherine C Michelis","doi":"10.15420/usc.2024.34","DOIUrl":"10.15420/usc.2024.34","url":null,"abstract":"<p><p>Coronary artery disease is the leading cause of death in the US, and approximately 25% of MIs occurring each year are reinfarctions. Due to advances in percutaneous coronary intervention (PCI) and medical therapy, patients with prior MIs live longer but may be susceptible to additional cardiac events. Thus, secondary prevention after MI or PCI is key to improving mortality and quality of life. This review discusses pharmacotherapies and lifestyle interventions with a special focus on cardiac rehabilitation in the post-MI or PCI period to improve cardiovascular outcomes.</p>","PeriodicalId":93393,"journal":{"name":"US cardiology","volume":"19 ","pages":"e01"},"PeriodicalIF":0.0,"publicationDate":"2025-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11836608/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143470250","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
US cardiologyPub Date : 2025-01-09eCollection Date: 2025-01-01DOI: 10.15420/usc.2024.56
Salwan Al-Hani, Luai Madanat, Aiden Van Loo, Simon R Dixon, Richard Bloomingdale
{"title":"Aortic Endograft Infection: Timely Recognition Is Key.","authors":"Salwan Al-Hani, Luai Madanat, Aiden Van Loo, Simon R Dixon, Richard Bloomingdale","doi":"10.15420/usc.2024.56","DOIUrl":"10.15420/usc.2024.56","url":null,"abstract":"","PeriodicalId":93393,"journal":{"name":"US cardiology","volume":"19 ","pages":"e02"},"PeriodicalIF":0.0,"publicationDate":"2025-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11836607/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143470249","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
US cardiologyPub Date : 2024-12-20eCollection Date: 2024-01-01DOI: 10.15420/usc.2024.23
Hanad Bashir, Pooja Prasad, Cali Clark, Ankit Bhatia, William T Abraham
{"title":"Remote Monitoring in Heart Failure: Revolutionizing Patient Management and Outcomes.","authors":"Hanad Bashir, Pooja Prasad, Cali Clark, Ankit Bhatia, William T Abraham","doi":"10.15420/usc.2024.23","DOIUrl":"10.15420/usc.2024.23","url":null,"abstract":"<p><p>Heart failure (HF) is a global health issue, contributing significantly to morbidity and mortality, particularly in North America. The management of HF is complex, requiring diligent monitoring to prevent decompensation and clinical progression. While there have been improvements in treating HF, it still leads to significant negative health outcomes and heavily contributes to the use of healthcare services. Outpatient management for HF lacks consistent application of proven therapies and the early identification and management of worsening conditions. Remote monitoring (RM) offers a solution to these challenges and there has been growing attention from HF healthcare providers and medical systems. This review explores the evolution and role of RM in the ambulatory care of HF patients, particularly emphasizing the impact of RM on clinical outcomes amid the COVID-19 pandemic.</p>","PeriodicalId":93393,"journal":{"name":"US cardiology","volume":"18 ","pages":"e23"},"PeriodicalIF":0.0,"publicationDate":"2024-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11770524/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143054627","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
US cardiologyPub Date : 2024-12-20eCollection Date: 2024-01-01DOI: 10.15420/usc.2024.37
Kaoutar Kabbadj, Nora Taiek, Wiame El Hjouji, Oumaima El Karrouti, Abdelkader Jalil El Hangouche
{"title":"Cardiopulmonary Exercise Testing: Methodology, Interpretation, and Role in Exercise Prescription for Cardiac Rehabilitation.","authors":"Kaoutar Kabbadj, Nora Taiek, Wiame El Hjouji, Oumaima El Karrouti, Abdelkader Jalil El Hangouche","doi":"10.15420/usc.2024.37","DOIUrl":"10.15420/usc.2024.37","url":null,"abstract":"<p><p>Cardiopulmonary exercise testing (CPET) is a crucial tool for assessing cardiorespiratory function, providing invaluable insights into individual physiological capacities. This review explores the clinical indications of CPET, its contraindications, as well as a comprehensive protocol for its execution. Additionally, it highlights key parameters measured during CPET and their interpretation, as well as the role of CPET in the prescription of aerobic training in cardiac rehabilitation. This review aims to provide a comprehensive, up-to-date synthesis of advances in the field of CPET and their clinical implications.</p>","PeriodicalId":93393,"journal":{"name":"US cardiology","volume":"18 ","pages":"e22"},"PeriodicalIF":0.0,"publicationDate":"2024-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11770537/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143054611","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
US cardiologyPub Date : 2024-11-13eCollection Date: 2024-01-01DOI: 10.15420/usc.2024.02
Preet Shaikh, Mario Rodriguez Rivera, Michael A Beal, Matthew R Schill, Amit Pawale, Jonathan D Moreno
{"title":"Giant Left Atrial Myxoma Presenting with Severe Pulmonary Hypertension.","authors":"Preet Shaikh, Mario Rodriguez Rivera, Michael A Beal, Matthew R Schill, Amit Pawale, Jonathan D Moreno","doi":"10.15420/usc.2024.02","DOIUrl":"10.15420/usc.2024.02","url":null,"abstract":"<p><p>The etiology of cardiac tumors has a broad differential diagnosis. The use of a multidisciplinary team along with appropriate workup with multimodality imaging is critical for patient management. A 41-year-old man with a history of heavy tobacco use presented with abdominal distension, edema, and dyspnea for the past month. Prior to this presentation, he had experienced two episodes of right upper extremity and left lower extremity paresthesias that resolved spontaneously. A chest computed tomography (CT scan revealed an 8.5 cm mass that obliterated the left atrium and protruded across the mitral valve. Multimodal imaging (transthoracic echocardiography and cardiac MRI) confirmed a diagnosis of myxoma. Highlighting the severity of the presentation, hemodynamics revealed severe pulmonary hypertension. The patient underwent surgical resection with complete resolution of symptoms. Atrial myxomas are rare, but are among the most common type of benign cardiac tumors. Prompt optimization and definitive surgical management are critical.</p>","PeriodicalId":93393,"journal":{"name":"US cardiology","volume":"18 ","pages":"e19"},"PeriodicalIF":0.0,"publicationDate":"2024-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11588102/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142717702","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
US cardiologyPub Date : 2024-11-13eCollection Date: 2024-01-01DOI: 10.15420/usc.2024.19
Deniz Mutlu, Ibrahim Halil Inanc, Ozgecan Piril Zanbak Mutlu, Konstantinos Marmagkiolis, Cezar A Iliescu, Mehmet Cilingiroglu
{"title":"Successful Percutaneous Transcatheter Aortic Valve Replacement for Severe Aortic Regurgitation in a High-risk Patient with Cardiorenal Syndrome.","authors":"Deniz Mutlu, Ibrahim Halil Inanc, Ozgecan Piril Zanbak Mutlu, Konstantinos Marmagkiolis, Cezar A Iliescu, Mehmet Cilingiroglu","doi":"10.15420/usc.2024.19","DOIUrl":"10.15420/usc.2024.19","url":null,"abstract":"<p><p>The absence of a Food and Drug Administration-approved percutaneous valve technology for the treatment of severe aortic regurgitation (AR) presents a challenge for high-risk patients. In this report, we describe the successful treatment of an 84-year-old male patient suffering from severe symptomatic AR and concomitant cardiorenal syndrome with renal failure using a 34 mm Evolut R (Medtronic) self-expanding transcatheter aortic valve replacement. This intervention resulted in the resolution of AR, cardiorenal syndrome, and congestive heart failure symptoms.</p>","PeriodicalId":93393,"journal":{"name":"US cardiology","volume":"18 ","pages":"e20"},"PeriodicalIF":0.0,"publicationDate":"2024-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11588104/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142717716","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
US cardiologyPub Date : 2024-11-08eCollection Date: 2024-01-01DOI: 10.15420/usc.2024.18
Kadijah F Porter, Brototo Deb, Andriy Katyukha, Natdanai Punnanithinont, Michael G Fradley, Stephen C Cook
{"title":"Reporting Sex and Gender Differences in Cardiovascular Research.","authors":"Kadijah F Porter, Brototo Deb, Andriy Katyukha, Natdanai Punnanithinont, Michael G Fradley, Stephen C Cook","doi":"10.15420/usc.2024.18","DOIUrl":"10.15420/usc.2024.18","url":null,"abstract":"<p><p>Incorporating sexual orientation, gender identity, and expression (SOGIE) data into cardiovascular research design is necessary to reduce cardiovascular healthcare disparities among sexual and gender minority (SGM) people. To achieve this, researchers should not only understand appropriate terminology, but also implement inclusive survey tools that respect privacy and cultural nuances, as the benefit of obtaining SOGIE information is critical to tailoring cardiovascular interventions and ensuring equitable healthcare outcomes. In order to address potential concerns related to disclosing SOGIE information, we must prioritize sensitivity training for healthcare professionals to foster an inclusive environment for data collection, ethical considerations, and confidentiality safeguards. This review aims to develop and inform critical thinking about sex and gender and to identify strategic mechanisms to include SOGIE data in cardiovascular research, thus improving cardiovascular health outcomes for SGM individuals. By embracing a more comprehensive and inclusive approach to data collection, cardiovascular research can contribute significantly to advancing personalized and inclusive healthcare practices and medical education, and ultimately promote better health outcomes for all SGM individuals.</p>","PeriodicalId":93393,"journal":{"name":"US cardiology","volume":"18 ","pages":"e18"},"PeriodicalIF":0.0,"publicationDate":"2024-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11588105/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142717705","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
US cardiologyPub Date : 2024-10-14eCollection Date: 2024-01-01DOI: 10.15420/usc.2023.21
Sukriti Banthiya, Larissa Check, Jessica Atkins
{"title":"Hypertrophic Cardiomyopathy as a Form of Heart Failure with Preserved Ejection Fraction: Diagnosis, Drugs, and Procedures.","authors":"Sukriti Banthiya, Larissa Check, Jessica Atkins","doi":"10.15420/usc.2023.21","DOIUrl":"10.15420/usc.2023.21","url":null,"abstract":"<p><p>Hypertrophic cardiomyopathy (HCM) is a complex and heterogeneous cardiac disorder characterized by cardiac hypertrophy disproportionate to loading stimuli (e.g. hypertension or aortic stenosis). Diagnosing HCM requires a thorough examination of clinical symptoms, with echocardiography as the key initial imaging tool. Multimodality imaging further supports diagnosis, helps assess left ventricular outflow obstruction, and aids in risk stratification for sudden cardiac death. The cornerstone of HCM management remains pharmacological therapy with β-blockers and calcium channel blockers serving as first-line agents to alleviate symptoms and reduce left ventricular outflow tract obstruction. More recently, cardiac myosin inhibitors have revolutionized the treatment paradigm for obstructive HCM. Procedural interventions such as septal reduction therapy are reserved for refractory cases. Genetic testing and risk stratification for sudden cardiac death play a critical role in treatment decisions, guiding further testing in first-degree relatives and ICD implantation in high-risk individuals. Exercise recommendations have evolved based on recent data, challenging traditional restrictions and emphasizing individualized plans.</p>","PeriodicalId":93393,"journal":{"name":"US cardiology","volume":"18 ","pages":"e17"},"PeriodicalIF":0.0,"publicationDate":"2024-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11539043/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142592183","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
US cardiologyPub Date : 2024-09-18eCollection Date: 2024-01-01DOI: 10.15420/usc.2023.24
Molly Silkowski, Payton Kendsersky, Nicholas Amoroso
{"title":"Functional Tricuspid Regurgitation in the Transcatheter Aortic Valve Replacement Population and Emerging Transcatheter Tricuspid Valve Interventions.","authors":"Molly Silkowski, Payton Kendsersky, Nicholas Amoroso","doi":"10.15420/usc.2023.24","DOIUrl":"10.15420/usc.2023.24","url":null,"abstract":"<p><p>Transcatheter aortic valve replacement (TAVR) has revolutionized the management of aortic valve disease. However, its success has brought attention to concurrent tricuspid valve disease and the inadequacy of treatments. This review explores the emerging field of transcatheter tricuspid valve interventions (TTVI) after TAVR. We address the pathophysiology and prevalence of post-TAVR tricuspid valve disease and TTVI strategies, including repair, replacement, annuloplasty, and edge-to-edge repair. We also discuss clinical studies assessing TTVI safety and efficacy, including for patients with previous TAVR. Collaboration among clinical disciplines remains crucial for advancing this emerging field to establish best practices regarding patient selection and procedural complexities.</p>","PeriodicalId":93393,"journal":{"name":"US cardiology","volume":"18 ","pages":"e16"},"PeriodicalIF":0.0,"publicationDate":"2024-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11539041/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142592174","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}